Results 101 to 110 of about 316,189 (194)

Lumbosacral Plexopathy: A Single‐Center Review of Etiology, Clinical Presentation, Electrodiagnostic Findings, and Long‐Term Outcomes

open access: yesMuscle &Nerve, Volume 74, Issue 4, Page 1220-1229, October 2026.
ABSTRACT Introduction/Aims Lumbosacral plexopathy (LSP) results from a spectrum of etiologies and can cause substantial functional impairment. Limited data exist on the relative distribution of etiologies and outcomes across broad tertiary‐care cohorts spanning multiple causes of LSP.
Bradley Ong   +4 more
wiley   +1 more source

Observing nociceptive detection thresholds and evoked potentials in diabetic patients with and without painful neuropathy

open access: yesExploration of Neuroscience
Aim: Diabetic polyneuropathy is the most described complication in patients with diabetes mellitus. A significant percentage of these patients experience disabling neuropathic pain (painful diabetic polyneuropathy).
Tom Berfelo   +4 more
doaj   +1 more source

Role of α-Lipoic Acid in Diabetic Polyneuropathy Treatment

open access: yesBiomolecules & Biomedicine, 2008
Diabetic neuropathy represents late diabetes complications, and diabetes duration and long-term hyperglycemia are the main reasons for polyneuropathy. The goal was to estimate the effects of alpha-lipoic acid on symptoms of diabetic neuropathy after 600
Azra Bureković   +4 more
doaj   +1 more source

Parameters of stimulation electroneuromyography of diabetic polyneuropathy

open access: yes, 2016
The authors have studied the indices of parameters of stimulation electroneuromyography, namely: the amplitude of the M-response and the rate of conducting excitations along the motor nerve fibers n. medianus; n. ulnaris; n. tibialis, n. peroneus 3 and 6
Pavlovych, L.B., Bilous, І.І.
core  

Real‐World Effectiveness and Safety of Finerenone in People With Type 2 Diabetes and Chronic Kidney Disease: A Spanish Multicentre Retrospective Observational Study (MEDFINE‐RWD)

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 10, Page 9461-9472, October 2026.
ABSTRACT Aim Although finerenone has shown efficacy in randomized trials, evidence from routine clinical practice remains limited. We aimed to assess the real‐world effectiveness and safety of finerenone in people with type 2 diabetes (PWT2D) and chronic kidney disease (CKD), with a particular focus on residual cardiorenal risk as reflected by changes ...
Oscar Moreno‐Pérez   +13 more
wiley   +1 more source

Comparative analysis of clinical and electroneuromyographic indicators in patients with secondary polyneuropathy

open access: yesБюллетень сибирской медицины, 2012
Analysis of clinical and electroneuromyographic performance of two groups of patients with secondary polyneuropathy showed that diabetic neuropathy affects the peripheral nerves of the lower extremities, whereas in polyneuropathy of mixed etiology ...
Ye. S. Korolyova   +3 more
doaj   +1 more source

Advances in the treatment of systemic lupus erythematosus: Biologicals, small‐molecular agents, and cell‐depleting therapies coming to the clinic

open access: yesJournal of Internal Medicine, Volume 300, Issue 4, Page 461-479, October 2026.
Abstract Systemic lupus erythematosus (SLE; lupus) remains a particular challenge for the practicing clinician on account of its chronic undulating and unpredictable course, its diverse manifestations, and—until recently—limited treatment options all associated with considerable downsides.
Ronald van Vollenhoven
wiley   +1 more source

Altered Semmes–Weinstein monofilament test results are associated with oxidative stress markers in type 2 diabetic subjects

open access: yesJournal of Translational Medicine, 2017
Background Different lines of evidence suggest that oxidative stress (OS) is implicated in the pathogenesis of diabetic neuropathy. The Semmes–Weinstein monofilament (SWM) test is an efficient tool for evaluating diabetic polyneuropathy and diabetic foot.
Sergio Martinez-Hervás   +7 more
doaj   +1 more source

Can diabetic polyneuropathy and foot ulcers in patients with type 2 diabetes be accurately identified based on ICD-10 hospital diagnoses and drug prescriptions?

open access: yes, 2019
Diana Hedevang Christensen,1,2 Søren Tang Knudsen,3 Sia Kromann Nicolaisen,1 Henning Andersen,2,4 Brian Christopher Callaghan,2,5 Nanna Brix Finnerup,2,4,6 Troels Staehelin Jensen,2,4,6 Reimar Wernich Thomsen11Department of Clinical Epidemiology ...
Knudsen ST   +7 more
core  

Off‐Label Initiation of Gabapentin and Valproic Acid Among Long‐Stay Nursing Home Residents With and Without Dementia

open access: yes
Journal of the American Geriatrics Society, EarlyView.
Lauren B. Gerlach   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy